This is a delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a biotechnology company and manufacturer of pharmaceuticals, for $96,150.00. The award is for the supply of oseltamivir phosphate (commonly known as Tamiflu), an antiviral medication. This delivery order is a part of a larger indefinite delivery contract between Genentech and DLA valued at $27.9 million to fulfill orders for medical supplies and critical pharmaceuticals supporting the Department of Defense's global health logistics network. The contract does not have a set-aside designation. Genentech is a foreign-owned, for-profit organization that provides a wide range of pharmaceutical products and services to various federal agencies, including the Department of Defense, Department of Health and Human Services, Department of Justice, and Department of Veterans Affairs.